Recent Articles

February 24, 2017 9:02 am
Mark Wainwright, Liverpool John Moores University, The Conversation
The new approach being developed by academics in the UK and Europe, uses dye molecules and light to kill bacteria, fungi, viruses and protozoa.
February 22, 2017 3:32 pm
Sy Pretorius, Corporate Vice President & Chief Scientific Officer; Anita Nelsen, Head of Genomic Medicine Services; and Mary Backstrom, Vice President, Marketing Strategy & Insights, PAREXEL International
Over the last decade, the cost of sequencing an individual’s genome has plunged from about $10 million to about $1,000.
February 21, 2017 10:53 am
Ryan Bushey
Pfizer is getting closer to gaining regulatory approval for an investigational leukemia treatment called inotuzumab ozogamicin.
February 20, 2017 3:00 pm
Dominic Trewartha, Managing Analyst, GBI Research
With a total of 2,145 products currently in development, the immunology market is experiencing a high level of investment compared to many other therapy areas.
February 17, 2017 2:40 pm
Ryan Bushey
British-based pharmaceutical firm AstraZeneca may be gaining an advantage in the burgeoning PARP inhibitor drug space.
February 17, 2017 8:35 am
Kenny Walter, Digital Reporter
Pluripotent stems cells can differentiate into any type of adult cell and have potential for tissue regeneration therapies, treating diseases and for research.
February 16, 2017 2:19 pm
Ryan Bushey
Boston-based Rhythm Pharmaceuticals obtained a new round of funding to help continue development of its lead peptide therapy setmelanotide.
February 15, 2017 2:46 pm
Ryan Bushey
A promising multiple sclerosis treatment called Ocrevus will play a crucial role in this growth.
February 15, 2017 8:41 am
Ryan Bushey
Investigators will gain a five-year appointment and up to $1.5 million in funding to kick start their research projects.
February 14, 2017 2:38 pm
Maxime Bourgonon, Ph.D., Healthcare Analyst, GlobalData
Ibrance and ribociclib are poised to dominate this drug class in terms of sales.
Subscribe to Drug Discovery & Development